2023. Efficacy of Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s255. DOI:https://doi.org/10.25251/skin.7.supp.255.